$SIBN

SI-BONE, Inc.

CIK:0001459839|SEC Filings

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Revenue	$ 56,010	$ 48,630	$ 108,598	$ 95,920
Cost of goods sold	11,462	9,823	22,106	19,418
Gross profit	44,548	38,807	86,492	76,502
Operating expenses:
Sales and marketing	34,024	30,781	66,832	61,462
Research and development	5,221	4,309	9,413	8,843
General and administrative	10,109	10,721	20,146	20,681
Total operating expenses	49,354	45,811	96,391	90,986
Loss from operations	(4,806)	(7,004)	(9,899)	(14,484)
Interest and other income (expense), net:
Interest income	1,332	1,520	2,682	3,112
Interest expense	(598)	(666)	(1,190)	(1,328)
Other income (expense)	(16)	(2)	(15)	6
Net loss	(4,088)	(6,152)	(8,422)	(12,694)
Other comprehensive income (loss):
Changes in foreign currency translation	(70)	369	(230)	526
Unrealized loss on marketable securities	(44)	(29)	(199)	(110)
Comprehensive loss	$ (4,202)	$ (5,812)	$ (8,851)	$ (12,278)
Net loss per share, basic (in dollars per share)	$ (0.09)	$ (0.14)	$ (0.19)	$ (0.30)
Net loss per share, diluted (in dollars per share)	$ (0.09)	$ (0.14)	$ (0.19)	$ (0.30)
Weighted-average number of common shares used to compute basic net loss per share (in shares)	44,477,113	42,788,123	44,222,928	42,564,158
Weighted-average number of common shares used to compute diluted net loss per share (in shares)	44,477,113	42,788,123	44,222,928	42,564,158

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended				6 Months Ended		12 Months Ended
	Jun. 30, 2026	Mar. 31, 2026	Jun. 30, 2025	Mar. 31, 2025	Jun. 30, 2026	Jun. 30, 2025	Dec. 31, 2025
Cash flows from operating activities
Net loss	$ (4,088)	$ (4,334)	$ (6,152)	$ (6,542)	$ (8,422)	$ (12,694)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation					12,004	13,321
Depreciation and amortization					3,296	2,646
Accounts receivable credit losses					181	475	$ 570
Amortization of discount and premium on marketable securities					(1,080)	(1,740)
Inventory reserve					335	1,235
Amortization of debt issuance costs					59	59
Loss on disposal of property and equipment					586	628
Changes in operating assets and liabilities:
Accounts receivable					(1,442)	2,598
Inventory					(4,847)	(8,292)
Prepaid expenses and other assets					(83)	(93)
Accounts payable					2,228	583
Accrued liabilities and other					(4,400)	(3,464)
Net cash used in operating activities					(1,585)	(4,738)
Cash flows from investing activities
Maturities of marketable securities					87,130	104,100
Purchases of marketable securities					(93,478)	(98,770)
Purchases of property and equipment					(2,622)	(4,171)
Net cash (used in) provided by investing activities					(8,970)	1,159
Cash flows from financing activities
Proceeds from issuance of common stock under employee stock purchase plan					1,190	1,568
Proceeds from the exercise of stock options					472	768
Net cash provided by financing activities					1,662	2,336
Effect of exchange rate changes on cash and cash equivalents					(219)	445
Net decrease in cash and cash equivalents					(9,112)	(798)
Cash and cash equivalents at
Beginning of period		$ 42,240		$ 34,948	42,240	34,948	34,948
End of period	33,128		34,150		33,128	34,150	$ 42,240
Supplemental disclosure of non-cash information
Unpaid purchases of property and equipment					2,173	1,017
Right-of-use assets obtained in exchange for new lease liabilities	$ 54		$ 39		$ 6,633	$ 39

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 33,128	$ 42,240
Short-term investments	112,813	105,583
Accounts receivable, net of allowance for credit losses of $637 and $1,013, respectively	31,180	29,915
Inventory	38,389	33,897
Prepaid expenses and other current assets	4,402	4,480
Total current assets	219,912	216,115
Property and equipment, net	21,719	21,298
Operating lease right-of-use assets	6,911	1,087
Other non-current assets	216	55
TOTAL ASSETS	248,758	238,555
Current liabilities:
Accounts payable	8,537	4,631
Accrued liabilities and other	15,079	19,704
Operating lease liabilities, current portion	426	944
Total current liabilities	24,042	25,279
Long-term borrowings	35,628	35,569
Operating lease liabilities, net of current portion	6,741	175
TOTAL LIABILITIES	66,411	61,023
Commitments and contingencies (Note 6)
STOCKHOLDERS’ EQUITY
Preferred stock, $0.0001 par value; 5,000,000 shares authorized; no shares issued and outstanding	0	0
Common stock, $0.0001 par value; 100,000,000 shares authorized; 44,697,215 and 43,647,131 shares issued and outstanding, respectively	4	4
Additional paid-in capital	640,636	626,970
Accumulated other comprehensive income	387	816
Accumulated deficit	(458,680)	(450,258)
TOTAL STOCKHOLDERS’ EQUITY	182,347	177,532
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 248,758	$ 238,555